AbbVie ABBV Accounts Receivable
Accounts Receivable at other companies
Other financials
Where this comes from
Reported directly by AbbVie in its filing.
Tagged under the XBRL concept us-gaap:AccountsReceivableNetCurrent.
The official record: AbbVie’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about AbbVie's accounts receivable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is AbbVie's accounts receivable?
- AbbVie (ABBV) reported accounts receivable of $12.48B in Q1 2026.
- How has AbbVie's accounts receivable changed year-over-year?
- AbbVie's accounts receivable increased by 0.0% year-over-year, from $12.48B to $12.48B.
- What is the long-term trend for AbbVie's accounts receivable?
- Over 5 years (2020 to 2025), AbbVie's accounts receivable has grown at a 7.4% compound annual growth rate (CAGR), from $8.82B to $12.59B.
- What does accounts receivable mean?
- Amounts owed by customers for goods delivered or services performed, net of allowances for doubtful accounts. A key working capital component.